Trials / Completed
CompletedNCT07378280
Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With NAFLD
A Randomized, Double-blinded, Placebo-controlled, Multi-center Study to Investigate the Effect of L. Lactis CKDB001 Administration on Liver Aminotransferases in Subjects With Nonalcoholic Fatty Liver Disease
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 95 (actual)
- Sponsor
- Chuncheon Sacred Heart Hospital · Academic / Other
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A study for evaluating the safety and efficacy of L. lactis CKDB001 on liver aminotransferases in subjects with nonalcoholic fatty liver disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Probiotics (L. lactis CKDB001) | L. lactis CKDB001: Enteric coated capsule with L. lactis CKDB001, daily, 12 weeks |
| DIETARY_SUPPLEMENT | Placebo | Placebo: Enteric coated capsule without any probiotics, daily, 12 weeks |
Timeline
- Start date
- 2021-08-18
- Primary completion
- 2023-08-02
- Completion
- 2023-11-24
- First posted
- 2026-01-30
- Last updated
- 2026-01-30
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT07378280. Inclusion in this directory is not an endorsement.